Envestnet Asset Management Inc Eli Lilly & CO Transaction History

Envestnet Asset Management Inc

$281 Billion
Q2 2024

A detailed history of Envestnet Asset Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Envestnet Asset Management Inc holds 895,054 shares of LLY stock, worth $785 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

895,054

Previous 854,367 4.76%

Holding current value

$785 Million

Previous $665 Million 21.92%

% of portfolio

0.29%

Previous 0.25%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$724.87 - $909.04 $29.5 Million - $37 Million	40,687 Added 4.76%	895,054 $810 Million
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $33.5 Million - $44.8 Million	56,517 Added 7.08%	854,367 $665 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $4.01 Million - $4.73 Million	-7,637 Reduced 0.95%	797,850 $465 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $64.8 Million - $89.4 Million	149,183 Added 22.73%	805,487 $433 Million
Q2 2023 Aug 04, 2023	SELL	$350.74 - $468.98 $624 Million - $834 Million	-1,777,769 Reduced 73.04%	656,304 $308 Million
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $575 Million - $675 Million	1,850,187 Added 316.87%	2,434,073 $836 Million
Q4 2022 Feb 07, 2023	BUY	$321.55 - $374.67 $4.62 Million - $5.38 Million	14,364 Added 2.52%	583,886 $214 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $4.74 Million - $5.4 Million	-15,994 Reduced 2.73%	569,522 $184 Million
Q2 2022 Aug 03, 2022	BUY	$278.73 - $327.27 $40 Million - $47 Million	143,571 Added 32.49%	585,516 $190 Million
Q1 2022 May 04, 2022	BUY	$234.69 - $291.66 $5.11 Million - $6.35 Million	21,759 Added 5.18%	441,945 $127 Million
Q4 2021 Feb 04, 2022	BUY	$224.85 - $279.04 $16.6 Million - $20.6 Million	73,713 Added 21.28%	420,186 $116 Million
Q3 2021 Oct 07, 2021	BUY	$221.6 - $272.71 $5.7 Million - $7.02 Million	25,724 Added 8.02%	346,473 $80.1 Million
Q2 2021 Aug 04, 2021	BUY	$180.55 - $233.54 $3.32 Million - $4.3 Million	18,406 Added 6.09%	320,749 $73.6 Million
Q1 2021 May 04, 2021	BUY	$164.32 - $212.72 $3.16 Million - $4.1 Million	19,253 Added 6.8%	302,343 $56.5 Million
Q4 2020 Feb 02, 2021	SELL	$130.46 - $172.63 $1.87 Million - $2.48 Million	-14,348 Reduced 4.82%	283,090 $47.8 Million
Q3 2020 Oct 09, 2020	SELL	$146.22 - $169.13 $2.01 Million - $2.33 Million	-13,769 Reduced 4.42%	297,438 $44 Million
Q2 2020 Jul 08, 2020	BUY	$136.42 - $164.18 $680,053 - $818,437	4,985 Added 1.63%	311,207 $51.1 Million
Q1 2020 Apr 23, 2020	BUY	$119.05 - $147.35 $2.15 Million - $2.66 Million	18,068 Added 6.27%	306,222 $42.5 Million
Q4 2019 Feb 11, 2020	BUY	$106.92 - $132.43 $2.08 Million - $2.57 Million	19,423 Added 7.23%	288,154 $37.9 Million
Q3 2019 Oct 17, 2019	BUY	$106.79 - $116.16 $1.4 Million - $1.52 Million	13,110 Added 5.13%	268,731 $30.1 Million
Q2 2019 Aug 02, 2019	SELL	$110.79 - $129.32 $3.4 Million - $3.97 Million	-30,678 Reduced 10.72%	255,621 $28.3 Million
Q1 2019 May 10, 2019	SELL	$111.31 - $131.02 $3.42 Million - $4.02 Million	-30,694 Reduced 9.68%	286,299 $37.2 Million
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $33.1 Million - $37.1 Million	312,755 Added 7379.78%	316,993 $36.7 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $4.1 Million - $5.12 Million	-47,708 Reduced 91.84%	4,238 $455,000
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $116,729 - $133,968	-1,542 Reduced 2.88%	51,946 $4.43 Million
Q1 2018 May 09, 2018	SELL	$74.21 - $87.6 $12.7 Million - $15 Million	-171,369 Reduced 76.21%	53,488 $4.14 Million
Q4 2017 Feb 20, 2018	BUY	$81.94 - $87.89 $586,854 - $629,468	7,162 Added 3.29%	224,857 $19 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $77,301 - $85,796	1,003 Added 0.46%	217,695 $18.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	216,692	216,692 $17.8 Million

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Eli Lilly & CO Transaction History